Vaxart Inc.

The momentum for this stock is not very good. Vaxart Inc. is not a good value stock. Vaxart Inc. is not very popular among insiders. Vaxart Inc. is a mediocre stock to choose.
Log in to see more information.
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of...
VXRT Fundamental Data by TradingView

News

Vaxart reports inducement grants under Nasdaq listing rule
Vaxart reports inducement grants under Nasdaq listing rule

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the Company or Vaxart ) today announced that on August 26, 2024, the Compensation Committee of the...\n more…

Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical D
Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical D

Globe Newswire - Data show that Vaxart's HPV vaccine constructs stimulate specific T cell immune responses, reduce tumor size, and increase survival in an animal model of human papillomavirus (HPV)-related...\n more…

FY2024 EPS Estimates for Vaxart, Inc. Increased by Analyst (NASDAQ:VXRT)
FY2024 EPS Estimates for Vaxart, Inc. Increased by Analyst (NASDAQ:VXRT)

Ticker Report Vaxart, Inc. (NASDAQ:VXRT - Free Report) - Cantor Fitzgerald lifted their FY2024 EPS estimates for Vaxart in a note issued to investors on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan...\n more…

There's Reason For Concern Over Vaxart, Inc.'s (NASDAQ:VXRT) Massive 39% Price Jump
There's Reason For Concern Over Vaxart, Inc.'s (NASDAQ:VXRT) Massive 39% Price Jump

Simply Wall St Vaxart, Inc. ( NASDAQ:VXRT ) shares have had a really impressive month, gaining 39% after a shaky period beforehand...\n more…

97,000 Shares in Vaxart, Inc. (NASDAQ:VXRT) Acquired by Sequoia Financial Advisors LLC
97,000 Shares in Vaxart, Inc. (NASDAQ:VXRT) Acquired by Sequoia Financial Advisors LLC

Zolmax Sequoia Financial Advisors LLC bought a new stake in Vaxart, Inc. (NASDAQ:VXRT - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission...\n more…